
Bristol-Myers Squibb Company
Healthcare · USD
Price
$58.34
Cap
$119.5B
Earnings
2/2 beat
30d Trend
+1%
Upper half of range — momentum is positive
Target range: $37 – $85 (consensus: $61.59)
Consensus: Hold
Earnings history
Q4 2025
BEAT
1.26 vs 1.15
Q3 2025
BEAT
1.63 vs 1.48
Key macro factors
US Consumer Inflation Expectations Rise, Led by Gas Prices: Rising inflation could lead to increased operating costs for Bristol Myers Squibb, including expenses for raw materials, manufacturing, and distribution. It could also indirectly impact consumer healthcare spending, potentially affecting patient adherence or demand for certain treatments if disposable incomes are strained.
US March Jobs Report Shows Mixed Labor Market Picture: A mixed or weakening labor market can influence consumer confidence and healthcare insurance coverage. A decrease in insured individuals or shifts in employer-sponsored health plans could affect Bristol Myers Squibb's sales volumes and the dynamics of pharmaceutical reimbursement.
OPEC+ Agrees Symbolic Production Hike Amid Supply Issues: Fluctuations in oil prices, even if influenced by symbolic production adjustments, can impact global supply chains and transportation costs for Bristol Myers Squibb. This could potentially lead to higher cost of goods sold and consequently affect the company's profitability.
Bristol-Myers Squibb Company is a global biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, distribution, and sale of innovative medicines for serious diseases in areas such as oncology, hematology, immunology, and cardiovascular health.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
